Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to Pitavastatin

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|2|257-267

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.2, 2012-03, pp. : 257-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduction of protein synthesis and statin-induced cardiomyocyte cell death

By Rabkin Simon   Lodha Parth   Kong Jennifer  

Cardiovascular Toxicology, Vol. 7, Iss. 1, 2007-03 ,pp. : 1-9

Humana Press, Inc

Access to resources Recommend Favorite

Trimetazidine restores the positive adaptation to exercise training by mitigating statin‐induced skeletal muscle injury

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 9, Iss. 1, 2018-02 ,pp. : 106-118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin and Aspirin Use Among Hispanic and Latino Adults at High Cardiovascular Risk: Findings From the Hispanic Community Health Study/Study of Latinos

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Statin-Intolerant High-Risk Patients

By  

Current Vascular Pharmacology, Vol. 8, Iss. 5, 2010-01 ,pp. : 632-637

Bentham Science Publishers

Access to resources Recommend Favorite

Statin Administration and the Risk of New-Onset Diabetes

By  

World Heart Journal, Vol. , Iss. , 2017-01 ,pp. : 27-34

Nova Science Publishers, Inc.

Access to resources Recommend Favorite